|5Feb 16, 1:49 PM ET

Dickey Robert IV 5

5 · AngioGenex, Inc. · Filed Feb 16, 2022

Insider Transaction Report

Form 5
Period: 2021-12-31
Dickey Robert IV
DirectorOther
Transactions
  • Award

    Stock Option

    2021-09-02$0.13/sh+250,000$32,500850,000 total
    Exercise: $0.13From: 2021-09-02Exp: 2026-09-02Common Stock (250,000 underlying)

Documents

1 file
  • 5
    ownership.xmlPrimary